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Abstract 
Two enantiomerically pure thiosemicarbazone-proline conjugates with enhanced aqueous 
solubility, namely 2-hydroxy-3-methyl-(S)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde 
thiosemicarbazone [L-Pro-STSC or (S)-H2L] and 2-hydroxy-3-methyl-(R)-pyrrolidine-2-
carboxylate-5-methylbenzaldehyde thiosemicarbazone [D-Pro-STSC or (R)-H2L] have been 
synthesized and characterized by elemental analysis, spectroscopic methods (UV−vis, 1H and 
13C NMR) and ESI mass spectrometry. Metal complexation behavior of L-Pro-STSC, 
stoichiometry and thermodynamic stability of iron(II), iron(III), copper(II) and zinc(II) 
complexes in 30% (w/w) DMSO/H2O solvent mixture have been studied by pH-
potentiometric, UV−vis spectrophotometric, CD, EPR, 1H NMR spectroscopic and 
spectrofluorimetric measurements. By reaction of CuCl2∙2H2O with (S)-H2L and (R)-H2L, 
respectively, the complexes [Cu(S-H2L)Cl]Cl and [Cu(R-H2L)Cl]Cl have been prepared and 
comprehensively characterized. X-ray diffraction study of [Cu(R-H2L)Cl]Cl showed the 
formation of a square-planar copper(II) complex, which builds up stacks with interplanar 
separation of 3.3 Å. The antiproliferative activity of two chiral ligands and their 
corresponding copper(II) complexes has been tested in two human cancer cell lines, namely 
SW480 (colon carcinoma) and CH1 (ovarian carcinoma). The thiosemicarbazone-proline 
conjugates L-Pro-STSC and D-Pro-STSC show only moderate cytotoxic potency with IC50 
values of 62 and 75 µM, respectively, in CH1 cells and > 100 µM in SW480 cells. However, 
the corresponding copper(II) complexes are 13 and 5 times more potent in CH1 cells, based 
on comparison of IC50 values, and in SW480 cells the increase in antiproliferative activity is 
even higher. In both tested cell lines the L-Pro-STSC as well as its copper(II) complex show 
slightly stronger antiproliferative activity than the compounds with a D-Pro moiety, yielding 
IC50 values of 4.6 and 5.5 µM, for [Cu(L-Pro-STSC)Cl]Cl in CH1 and SW480 cells, 
respectively.  
 
Introduction 
Thiosemicarbazones (TSCs) are strong chelating ligands for transition metals with a broad 
spectrum of biological activity.1,2 α(N)-Heterocyclic TSCs are known as potential antitumor 
drugs.3,4 Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) is the most 
prominent example of this family of compounds and has been extensively studied as a single 
agent and in combinations with established drugs in phase I and II clinical trials with mixed 
results.5–8 Triapine and other related TSCs, as well as their metal complexes, are known as 
strong inhibitors of ribonucleotide reductase (RNR), an important enzyme promoting the 
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production of deoxyribonucleotides required for DNA synthesis and cell proliferation,9–14 
while some copper(II) thiosemicarbazonates inhibit topoisomerase IIα, an enzyme responsible 
for regulation of DNA topology15–17 or induce oxidative stress.18 The formation of an iron(II) 
complex with Triapine, its reaction with molecular oxygen and subsequent formation of 
reactive oxygen species (ROS) which destroy the tyrosyl radical of RNR are considered the 
main steps in their mode of action.19,20 A potential specific binding pocket for Triapine on the 
surface of the mouse R2 RNR protein has been proposed quite recently.21 The ability of TSCs 
to act as chelators of transition metal ions is well documented in the literature by isolation and 
characterization of the resulting complexes in the solid state,22 and, by solution equilibrium 
studies, which provide valuable information about the chemical species present in aqueous 
solution at physiological pH and their thermodynamic stability.23 Studies in solution are of 
utmost importance for understanding the mechanism of action of biologically active 
compounds and design of even stronger chelators. However, such investigations are very 
often hampered by the low aqueous solubility of TSCs.  
 
2-Hydroxybenzaldehyde (or salicylaldehyde) TSC (STSC) was also reported to form 
complexes with transition metals.24 However, this organic compound shows only a moderate 
cytotoxic activity in tumor cells,25,26 in comparison with α(N)-heterocyclic TSCs exhibiting 
IC50 values in the low micromolar or even high nanomolar range,
27,22f and the reasons for this 
dramatic drop in activity are still unknown. The antiproliferative activity of STSC can be 
enhanced to some extent by attachment of polar, electron-donating substituents, e.g. 
dimethylamino and/or methoxy group(s) to the 2-hydroxybenzaldehyde moiety26 or by 
coordination to metal ions.25  
  
Copper(II) chloride forms a square-planar complex with 2-hydroxy-3-methoxybenzaldehyde 
TSC (HL) of 1:1 stoichiometry, namely [Cu(L)Cl]∙H2O.
28 The methoxy group and the co-
crystallized water molecule are involved in formation of one-dimensional planar chains via 
intermolecular hydrogen-bonding interactions. By reaction of copper(II) sulfate with 
salicylaldehyde-β-D-glycoside TSC followed by re-crystallization of the precipitate from 
DMSO the complex [Cu(L1)(H2O)]2SO4∙2DMSO, where HL
1 = 2-hydroxybenzaldehyde TSC, 
was isolated and characterized. The crystal structure consists of centrosymmetric dinuclear 
cations stabilized by −* interaction between four-coordinate square-planar monocations. 
The X-ray diffraction structures of both copper(II) complexes imply that both species are 
potential DNA intercalators. Moreover, it has been reported recently, that square-planar 
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coordination geometry of some copper(II) TSCs is likely the biologically active configuration 
in Topo-II inhibition via an ATP binding site-based mechanism.16,17 
 
Reports on thermodynamic stability of the metal complexes of STSC and its derivatives are 
scarce in the literature,29 because of their generally low aqueous solubility hampering solution 
equilibrium studies. Quite recently some of us studied in detail the stoichiometry and 
thermodynamic stability of iron(II), iron(III), copper(II), zinc(II) and gallium(III) complexes 
with STSC in water/dimethyl sulfoxide (DMSO) mixture by pH-potentiometric, UV−vis 
spectrophotometric, EPR, 1H NMR spectroscopic and spectroﬂuorimetric measurements and 
compared these data with those for (N)-heterocyclic TSCs.23b,c,29 Herein we report on the 
synthesis and spectroscopic characterization of two enantiomerically pure Pro-STSC 
conjugates with enhanced aqueous solubility, namely, 2-hydroxy-3-methyl-(S)-pyrrolidine-2-
carboxylate-5-methylbenzaldehyde thiosemicarbazone [L-Pro-STSC or (S)-H2L] and 2-
hydroxy-3-methyl-(R)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde thiosemicarbazone 
[D-Pro-STSC or (R)-H2L] (Scheme 1). Metal complexation behavior of L-Pro-STSC, 
stoichiometry and thermodynamic stability of iron(II) and iron(III), copper(II) and zinc(II) 
complexes in 30% (w/w) DMSO/H2O solvent mixture have been studied by pH-
potentiometric, UV−vis spectrophotometric, EPR, 1H NMR, CD spectroscopic and 
spectroﬂuorimetric measurements. In addition, the isolation and characterization of square-
planar copper(II)  complexes with enantiomerically pure Pro-STSC conjugates in the solid 
state are reported. The effect of copper(II) coordination, as well as chirality of the Pro moiety 
on the antiproliferative activity of conjugates in two human cancer cell lines has been studied 
as well. 
 
Results and Discussion 
Synthesis and characterization of chiral thiosemicarbazones. The chiral 
thiosemicarbazone-proline conjugates have been prepared in three steps as shown in Scheme 
1. First 3-chloromethyl-2-hydroxy-5-methylbenzaldehyde30 was allowed to react with L- or 
D-proline methyl ester hydrochloride in the presence of triethylamine with formation of 
compounds (S)-1 and (R)-1, respectively. Condensation reactions of these latter compounds 
with thiosemicarbazide followed by hydrolysis of the methyl ester groups afforded the 
corresponding TSCs with coupled via a methylene group Pro moiety [(S)-H2L and (R)-H2L]. 
The formation of desired species has been confirmed by 1H and 13C NMR measurements, as 
well as by ESI mass spectra. The number of 1H and 13C resonances in NMR spectra is in 
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accord with the proposed structure of C1 point symmetry. The mass spectra recorded in 
positive ion mode showed peaks at m/z 359 and 337 due to [M+Na]+ and [M+H]+ ions, 
respectively. The pH-metric titrations (vide infra) suggest that L-Pro-STSC is tribasic in the 
studied pH-range and adopts a zwitterionic structure as shown in Scheme 2.  
 
Scheme 1. Synthesis of chiral thiosemicarbazone-proline derivatives (S)-H2L and (R)-H2L.
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aReagents and conditions: (i) methyl (S)-pyrrolidine-2-carboxylate hydrochloride, 
triethylamine, THF/CH2Cl2 1.5:1, rt, purification by column chromatography [(S)-1, 51%]; 
(ii) methyl (R)-pyrrolidine-2-carboxylate hydrochloride, triethylamine, THF/CH2Cl2 1.5:1, rt, 
purification by column chromatography [(R)-1, 39%]; (iii) thiosemicarbazide, EtOH/H2O 1:1, 
70–75 °C, 75 h, [(S)-H2L, 41%]; (iv) thiosemicarbazide, EtOH/H2O 1:1, 70–75 °C, 12 h, 
[(R)-H2L, 18%]. 
 
Scheme 2. Deprotonation steps of H3L
+ (relevant for both Pro-STSC enantiomers).a  
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a Atom labeling was introduced for assignment of proton resonances. 
 
Aqueous solutions of L- and D-Pro-STSC ligands at neutral pH are indeed optically active 
and show Cotton effects for both enantiomers (see Figure S1A). As expected they are roughly 
mirror images over the 240−400 nm region of the circular dichroism (CD) spectra, while their 
UV–vis spectra are identical.  
 
Synthesis and characterization of [Cu(S-H2L)Cl]Cl and [Cu(R-H2L)Cl]Cl. By reaction of 
methanolic solution of CuCl2∙2H2O with (S)-H2L and (R)-H2L the complexes [Cu(S-
H2L)Cl]Cl and [Cu(R-H2L)Cl]Cl have been isolated in 55 and 84% yield, respectively. The 
positive ion ESI mass spectra showed the presence of a strong peak at m/z 398 attributed to 
[Cu(II)(HL)]+. In the negative ion mass spectra ions with m/z 396 and 432 due to 
[Cu(II)(L−H)]− and [Cu(II)LCl]−, respectively, were observed. The protonation form of the 
Pro-STSC ligand adopted in the prepared copper(II) complexes has been unequivocally 
established by X-ray diffraction study of [Cu(II)(R-H2L)Cl]Cl. Note that for the charge 
neutral coordinated ligand in this complex we use for consistency the same abbreviation H2L, 
although the charge distribution differs from that shown in Scheme 2.  
 
The CD spectra of both copper(II) complexes of L-Pro-STSC and D-Pro-STSC were recorded 
at pH 7.4 in the UV range in pure aqueous solution (Figure S1B), which clearly show the 
presence of enantiomerically pure species.  
 
X-ray Crystallography. X-ray diffraction quality crystals were obtained by slow diffusion of 
diethyl ether into methanolic solution of [Cu(R-H2L)Cl]Cl. The result of X-ray diffraction 
study of [Cu(R-H2L)Cl]Cl is shown in Figure 1. The complex crystallizes in the non-
centrosymmetric monoclinic space group P21 with two crystallographically independent ionic 
complexes in the asymmetric unit. The copper(II) ion has a square-planar coordination 
geometry. The multidentate ligand (H2L) uses only in part its donor capacity and acts in the 
complex as a tridentate one, binding to Cu2+ via phenolate oxygen O1a, imine nitrogen N1a 
and thione atom S1a. The bond length C8a−S1a of 1.698(6) is equal within 3 with that in 
[Cu(L)Cl]∙H2O,
28 where HL = 2-hydroxy-3-methoxybenzaldehyde thiosemicarbazone. The 
fourth position in the coordination polyhedron is occupied by a chlorido ligand. In addition, 
the thiosemicarbazone ligand is protonated at proline nitrogen atom N4a. Protonation is 
corroborated by difference Fourier map and by the presence of intramolecular bifurcated 
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hydrogen bonding interaction N4a−H∙∙∙O1a [N4a∙∙∙O1a 2.695(5) Å, N4a−H∙∙∙O1a 131.1°] and 
N4a−H∙∙∙O2a [N4a∙∙∙O2a 2.696(5) Å, N4a−H∙∙∙O2a 113.8°]. The nitrogen atom N2a acts as 
proton donor in hydrogen bonding interaction N2a−H∙∙∙Cl2 [N2a∙∙∙Cl2 3.072(5) Å, 
N2a−H∙∙∙Cl2 147.9°], while O3a in H-bond O3a−H∙∙∙Cl1ai [O3a∙∙∙Cl1ai 3.038(4) Å, 
O3a−H∙∙∙Cl1ai 171.1°], where i denotes symmetry related Cl1a atom generated via symmetry 
code x−1, y, z. Other hydrogen bonding interactions are shown in the unit cell plot in Figure 
S2. The two crystallographically independent complex cations form stacks in the crystal via 
-* interactions with interplanar separation of about 3.3 Å as shown in Figure S3. All this 
implies that copper(II) complexes can be considered as potential DNA intercalators similarly 
to other square-planar metal complexes with chemically related ligands.31 
 
 
Figure 1. ORTEP view of one of the crystalloghraphically independent cations [Cu(R-
H2L)Cl]
+ with thermal displacement ellipsoids drawn at 50% probability level. Selected bond 
distances (Å) and bond angles (deg): Cu1a−Cl1a 2.2669(16), Cu1a−S1a 2.2256(15), 
Cu1a−O1a 1.887(3), Cu1a−N1a 1.956(4), C1a−O1a 1.321(7), C1a−C6a 1.404(8), C6a−C7a 
1.422(7), C7a−N1a 1.291(7), N1a−N2a 1.392(6), N2a−C8a 1.336(7), C8a−S1a 1.706(6), 
C8a−N3a 1.311(6), C15a−O2a 1.193(6), C15a−O3a 1.330(5); O1a−Cu1a−N1a 92.17(17), 
N1a−Cu1a−S1a 87.26(13), S1a−Cu1a−Cl1a 90.44(6), O1a−Cu1a−Cl1a 90.49(12).  
 
Solution Chemistry 
Proton dissociation processes and lipophilicity. Proton-dissociation processes of (S)-H2L 
(Scheme 2) were followed by pH-potentiometry, UV–vis spectrophotometry and 
spectrofluorimetry as well as 1H NMR titrations. Measurements were performed in a 30% 
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(w/w) DMSO/H2O solvent mixture. Consecutive titrations showed that no ligand 
decomposition occurred in the pH range studied under the argon atmosphere. Three proton 
dissociation constants could be determined by different methods (Table 1) and constants 
obtained are in reasonably good agreement. pK1 can presumably be attributed to 
deprotonation of the carboxylic group in (S)-H3L
+, while pK2 belongs presumably to the 
phenolic OH. pK3 can be related to the proton dissociation of the N
2–H group of the 
thiosemicarbazide moiety or proton dissociation of the tertiary Pro nitrogen. Based on the 
methods used we cannot distinguish these most probably overlapping deprotonation 
processes. It is worth noting that the magnitudes of pK1 and pK3 values, low and high, 
respectively, hamper their accurate determination by pH-metry as these deprotonation steps 
take place in the pH ranges where the pH measurements become uncertain. 
 
Table 1. Proton dissociation constants (pKa) of the ligand L-Pro-STSC determined by various 
methods;a lmax and molar absorptivity (M
−1cm−1) values for ligand species H2L, HL
−, L2− 
determined by UV−vis spectrophotometric titrations and calculated chemical shifts (ppm) for 
H3L
+, H2L and HL
− obtained by 1H NMR titrations {T = 298 K, I = 0.10 M (KCl) in 30% 
(w/w) DMSO/H2O}. 
  pH-metry UV−vis 1H NMRb 
pK1
 2.17(8) − 2.36(5) 
pK2 7.90(3) 7.79(8) 7.85(2) 
pK3 11.88(12) 11.66(10) − 
 lmax (e /M
−1cm−1) 
H2L
  308 nm (19250); 336 nm (15820) 
HL– 302 nm (16490); 388 nm (11640) 
L2− 308 nm (14700); 362 nm (12200) 
d/ppmb C
14H  
(s) 
C4H 
(s) 
C6H 
 (s) 
C7H3 
(s) 
C8H2 
 (d)           (d) 
C9H 
 (m) 
H3L
+ 8.243 7.400 7.320 2.294 3.644 4.195 3.311 
H2L
  8.239 7.392 7.319 2.292 3.601 3.975 3.231 
HL– 8.420 7.609 7.043 2.184 3.294 3.743 2.916 
a The numbers in parentheses are standard uncertainties of the quoted pKa values. 
b 
Determined in 30% (w/w) d6-DMSO/H2O 
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The pH-dependent physico-chemical properties of the L-Pro-STSC ligand such as 
fluorescence emission, absorbance, chemical shifts were monitored by different spectroscopic 
methods with a different level of sensitivity to the certain proton dissociation processes. The 
UV–vis spectra are almost unchanged in the pH range where the deprotonation of the 
carboxylic group occurs (Figure 2), thus pK1 could not be determined by this method with 
acceptable accuracy. Deprotonation of the phenolic OH is accompanied by a considerable 
shift of the lmax value from 336 to 388 nm and the colorless solution of the ligand turns into 
yellow. Two well-separated isosbestic points are seen at 355 and 373 nm due to the 
deprotonation equilibria H2L  HL
− + H+ and HL− L2− + H+, respectively. Therefore, 
pK2, pK3 values and the spectra of the individual ligand species (H2L; HL
–; L2–) (Table 1, 
Figure S4) were calculated on the basis of deconvolution of the UV–vis spectra. 
 
 
Figure 2. UV−vis spectra of L-Pro-STSC at different pH values (A); Concentration 
distribution curves for ligand species with the pH-dependence of absorbance values at 384 nm 
() (B) {cligand = 4.0 × 10
−5 M; T = 298 K, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}. 
 
L-Pro-STSC possesses intrinsic fluorescence due to its extended conjugated electronic system 
(see Figure 3 and inset for 3D fluorescence spectrum), which is a valuable property for e.g. 
monitoring cellular uptake or intracellular distribution of the ligand or its metal complexes by 
fluorescence microscopy. The fluorescence emission of L-Pro-STSC in its zwitterionic  H3L
+ 
or H2L forms is negligible at any excitation wavelength, however, the proton dissociation at 
the phenolic OH results in a significant increase of the intensity, which is diminished by the 
third deprotonation step above pH 10.5 (Figure 3). 
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Figure 3. Fluorescence emission spectra of L-Pro-STSC at different pH values {cligand = 5.1 × 
10−6 M; lEX = 393 nm; T = 298 K, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O; slits: 5 nm/5 
nm}. Inset shows the 3D fluorescence spectrum at pH 10.0 {slits: 2.5 nm/2.5 nm}. 
 
The pH-dependent 1H NMR spectra of the ligand (Figure S5) revealed that the protons C9H 
and C8H2 are most sensitive to the deprotonation of the COOH group. Therefore pK1 was 
calculated based on the changes of the chemical shifts (d) of these protons (Figure 4). The 
second proton dissociation step is accompanied by significant electronic shielding effects, 
namely upfield shifts of the C6H, C8H2 and C
9H protons, while the C14H and C4H resonances 
were downfield shifted upon increasing the pH (see Figure S5). Further changes were 
observed at pH > 11 due to the third deprotonation step, but data were not appropriate for 
calculation of the pK3 value. We should note here that C
8H2 protons are displayed in 
1H NMR 
spectra as two doublets because of the non-equivalent orientation in space of the two protons.  
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Figure 4. pH-dependence of the chemical shifts (d) of the various protons of the ligand L-
Pro-STSC: C14H (♦); C4H (▲); C6H (○); C8H2 (●,×); C
9H (∆) { T = 298 K; I = 0.10 M (KCl) 
in 30% (w/w) d6-DMSO/H2O}. For assignment of particular proton resonances see Scheme 2 
and Figure S5. 
 
It should be noted that the phenolic OH of the ligand L-Pro-STSC is considerably more acidic 
compared to that of reference STSC (pK = 8.8929). This is presumably due to the formation of 
a hydrogen bond between the phenolate group and the protonated nitrogen atom of the Pro 
moiety, which can stabilize the conjugate base, hence decrease the pK.  
 
Distribution coefficients (D) of L- and D-Pro-STSC were determined at pH 7.4 via the 
partitioning between n-octanol and water (Figure S6). The Pro-STSC conjugates show more 
hydrophilic character (logD7.4 = −0.56 ± 0.01 for the L- and −0.60 ± 0.01 for the D-
enantiomer) compared to the reference STSC (logD7.4 = +1.74)
29 or Triapine (logD7.4= 
+0.85).29 At physiological pH the Pro-STSC ligand is mainly present in the neutral form 
(75% H2L, 25% HL
−) and the carboxylic group is fully deprotonated. This relatively low 
logD value is manifested in enhanced aqueous solubility compared to other chemically 
related TSCs. The lipophilicity of both complexes was determined via n-octanol/water 
partitioning (Figure S7) at physiological pH. As expected similar logD7.4 = +0.25 ± 0.01 and 
+0.24 ± 0.01 values were obtained for the copper(II) complexes with L- and D-enantiomer, 
respectively, showing a more lipophilic character compared to the metal-free ligands. (It 
should be noted that the distribution coefficients were calculated strictly based on the aqueous 
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phase spectra and the logD7.4 values are equal to their partition coefficients (P) as the neutral 
[CuL] species predominate at this pH.) 
  
Complexation reactions of copper(II), zinc(II), iron(II) and iron(III) with L-Pro-STSC. 
The complex formation processes of the ligand L-Pro-STSC with Cu2+, Zn2+, Fe2+ and Fe3+ 
were studied primarily by pH-potentiometry in a 30% (w/w) DMSO/H2O solvent mixture. 
The complex formation with Fe3+ and Cu2+ starts at low pH (pH ~ 2) in the millimolar 
concentration range, while with Zn2+ and Fe2+ only at pH > 4, (see Figure 5 for Fe2+). 
Formation of some mixed hydroxido species occurred at basic pH mainly at 1:1.2 metal-to-
ligand ratio, as concluded from the base consumption exceeding the number of dissociable 
protons in the ligand. The stoichiometries of the metal complexes and the cumulative stability 
constants furnishing the best fits to the experimental data are listed in Table 2. Stability 
constant of the species [Fe(III)LH]2+ was determined by spectrophotometry on individual 
samples following the changes of the metal-to-ligand charge transfer (CT) and ligand bands 
in the region of 300 − 470 nm between pH 1 and 2. Then the determined value was kept 
constant during the pH-metric data evaluation. 
 
1
3
5
7
9
11
-1 0 1 2 3 4 5
p
H
base equivalent  
Figure 5. Representative pH-potentiometric titration curves for ligand (×) and for the Fe2+ − 
L-Pro-STSC system at 1:1.2 (○), 1:2.3 (◊), 1:3.3 (∆), 1:4.5 (■) metal-to-ligand ratios {cligand = 
2×10−3 M; 30% (w/w) DMSO/H2O); T = 298 K; I = 0.10 M (KCl)}. 
 
The data reveal formation of merely mono-ligand complexes of Cu2+ and Zn2+, while Fe2+ and 
Fe3+ ions, in addition, form bis-ligand complexes. Direct comparison of the overall stability 
constants undoubtedly shows the significantly higher stability of the Fe3+ and Cu2+ complexes 
over that of the Zn2+ and Fe2+ species. pM values have been computed to provide a basis for 
comparison of the relative chelating ability of L-Pro-STSC at physiological pH (Table 2). 
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(pM stands for the negative logarithm of the equilibrium concentrations of the free metal ion 
under certain conditions. pM* was also calculated for Fe3+ which involves the various 
hydroxido species [Fe(III)pHr], since they belong to the unbound fraction, in addition to the 
free Fe3+ ion). 
 
Table 2. Stability constants (logβ[MpLqHr]) for the Cu
2+, Zn2+, Fe2+ and Fe3+ complexes of 
the L-Pro-STSC with some stepwise constants and pM values {T = 298 K, I = 0.10 M (KCl) 
in 30% (w/w) DMSO/H2O}
a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to these pM (pM*) values the ligand effectiveness is varied in the following order 
at pH 7.4: Fe2+ ~ Zn2+ < Fe3+ < Cu2+. It is worth noting that L-Pro-STSC shows the formation 
of similar type of complexes and quite similar pM values with those of its reference model 
ligand, STSC. However, a slightly higher efficacy of L-Pro-STSC is seen in the case of Fe3+ 
and Zn2+.29 These findings suggest that both ligands coordinate in a similar fashion to the 
metal centers and the L-Pro moiety does not alter significantly the composition and stability 
of the metal complexes, but improves their aqueous solubility. In order to elucidate the most 
probable coordination modes of the L-Pro-STSC in metal complexes and to confirm the 
speciation obtained by the pH-potentiometry UV−vis, EPR, CD and 1H NMR spectroscopies 
were applied. 
 
 Cu2+ Zn2+ Fe2+ Fe3+ 
logβ([MLH]) 21.58(3) 18.12(3) 18.14(4) 22.39(4)b 
logβ([ML]) 17.54(3) 12.40(3) 12.24(6) 19.48(3) 
logβ([MLH–1]) 6.97(4) 2.51(3) – – 
logβ([ML2H]) – – 28.86(5) 38.24(3) 
logβ([ML2]) – – 21.07(6) 33.32(4) 
logβ([ML2H−1]) – – 10.99(7) 22.13(8) 
fitting parameter (mL) 5.15×10−3 5.52×10−3 8.64×10−3 3.01×10−3 
logK([ML2])
e – – 8.83 13.84 
pMc 13.4 8.3 8.2 18.9[d] 
a The numbers in parentheses are standard uncertainties for the stability 
constants of the complexes. Charges of the complexes are omitted for 
simplicity (H2L is charge-neutral). 
b Determined by UV−vis 
spectrophotometric measurements at pH = 1 − 2. c pM (= –log[M]) values 
at pH = 7.4; cM = 1×10
−6 M; M : L = 1:10. d pM* = −log([MpHr]) = 10.9 
at pH = 7.4; cM = 1×10
−6 M; M : L = 1:10.eK[ML2] stepwise constant is 
related to the equilibrium: ML + L ML2. The definition of the other 
overall stability constants is given in the Supporting Information. 
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S–Cu2+ ligand-to-metal CT bands and represent characteristic pH-dependent changes (Figure 
6A). The lmax of this band is decreased significantly parallel to the formation of species 
[CuL] from [CuLH]+. The formation of [CuLH−1]
− is accompanied by a smaller decrease of 
the lmax along with an increment in the ligand field and change of the coordination mode of 
the ligand in complexes (Figure 6B). As the ligand is optically active due to the presence of 
chirality at the proline moiety, CD spectra in the wavelength range 460–650 nm were 
recorded (Figure 6C). The location of the maxima and minima of peaks shows pH-
dependence and parallel changes with the transformation processes of the complexes are 
seen; e.g. the negative peak is shifted from 650 via 615 to 562 nm as species [CuL] and 
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Figure 6. UV–vis spectra of the Cu2+ – L-Pro-STSC system recorded at different pH values 
(A) with the corresponding concentration distribution curves calculated with the stability 
constants obtained by pH-metry depicted together with the lmax values plotted against pH (B) 
and the pH-dependent CD spectra of the system (C) {cM = 2.0 × 10
–3 M; M:L = 1:1; T = 298 
K, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}.  
 
EPR spectra of Cu2+–L-Pro-STSC species in 30% (w/w) DMSO/H2O recorded at various pH 
values at room temperature (Figure 7) and at 77 K (Figure S8) confirm the speciation 
obtained by the pH-potentiometry and reveal the coordination modes of the ligand in each 
Cu2+ complex. A two-dimensional simulation of the solution EPR spectra resulted in the 
individual isotropic EPR parameters of the different Cu2+– L-Pro-STSC species (Table 3). 
The fitted experimental and individual spectra are depicted in Figure 7. The isotropic values 
calculated by averaging the anisotropic values (go,calc and Ao,calc, Table 3) are in good 
agreement with the corresponding values measured in solution, indicating that the 
coordination modes adopted by the ligand in solution are preserved upon freezing. The 
nitrogen hyperfine splitting, caused by the equatorial coordination of one nitrogen atom, is 
well resolved in all component spectra. The deconvolution of the EPR spectra clearly shows 
that the species [CuLH]+ predominates in solutions already at pH ~ 2.5 – 3 and with 
increasing pH the species [CuL] is formed in a wide pH range (pH = 6 − 9), then above pH 10 
the species [CuLH−1]
− predominates. No dinuclear or bis-ligand complexes were found under 
these conditions. Based on the low go and high Ao isotropic values the tridentate coordination 
of L-Pro-STSC and nearly square-planar coordination geometry is suggested for all the 
complexes. In [CuLH]+ coordination of the ligand via phenolate O−, N1 and the thione-S, 
while the hydrazinic N2–H moiety is still protonated, is the most likely. (The carboxylic 
group is supposed to be deprotonated in all species in the partly aqueous solution.) 
Deprotonation of the hydrazinic N2–H group of the complex results in lower go and higher Ao 
parameters, thus the (O−, N1, S−) binding mode is feasible in the species [CuL]. Further 
decrease in go and increase in Ao values support the deprotonation of the water molecule 
coordinating in the fourth position of the square-planar complex [CuLH−1]
−. Thus this species 
is regarded as a mixed hydroxido complex, [CuL(OH)]–. Based on EPR data the same 
coordination modes are realized in the corresponding complexes of L-Pro-STSC and STSC,29 
and the carboxylate group of L-Pro-STSC is not involved in metal coordination. However, the 
line width in the component spectra of L-Pro-STSC and STSC29 differs significantly (Figure 
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7). The broader lines observed for the copper(II) complexes of L-Pro-STSC are due to the 
non-coordinating carboxylate group of the ligand, which leads to a slightly hindered rotation 
of these complexes in solution. As a consequence, the orientation dependent EPR parameters 
are not completely averaged out, and the fourth copper line detected in the lower field 
becomes very broad. Therefore, the simulated spectra, using the equation MI = +MI+MI2 
for the line width description, showed a systematic deviation from the measured spectra at 
around 3350 G (Figure 7). 
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Figure 7. Experimental (black) and simulated (red) EPR spectra for Cu2+ – L-Pro-STSC 
system (left) and calculated component spectra for complexes [CuLH], [CuL]− and 
[CuLH−1]
2− (right) {cligand = 2 mM; M : L = 1:1; T = 298 K, I = 0.10 M (KCl) in 30% (w/w) 
DMSO/H2O}. 
 
Table 3. Isotropic EPR parameters of the components obtained for Cu2+ – L-Pro-STSC 
system from the two-dimensional simulation of EPR spectraa,b 
 go Ao /G a0
N /G  / G  /G  /G 
Cu2+ c 2.1970 34.3 − 51.9 −2.2 0.7 
[CuLH]+ 2.1061(1) 66.1(1) 17.3(1) 35.5(1) −21.8(1) 3.9(1) 
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[CuL ] 2.0946(1) 76.7(1) 17.5(1) 32.9(1) −23.0(1) 5.3(1) 
[CuLH−1]
− 2.0872(2) 84.1(2) 14.9(2) 36.2(1) −26.5(1) 6.5(1) 
a The numbers in parentheses are standard uncertainties. b Anisotropic EPR 
parameters for [CuLH]: gx = 2.0509(1); gy = 2.0326(1); gz = 2.2236(1); Ax = 
25.4(2) G; Ay = 23.7(2) G; Az = 170.0(1) G; aNx = 6.1 G; aNy = 17.1 G; aNz = 
6.0 G; g0,calc = 2.1024; A0,calc = 75.85 G; for [CuL]
−: gx = 2.0497(1); gy = 
2.0251(1); gz = 2.2038(1); Ax = 16.3(2) G; Ay = 25.7(2) G; Az = 176.5(1) G; 
aNx = 15.3 G; aNy = 19.5 G; aNz = 6.0 G; g0,calc = 2.0929; A0,calc = 75.56 G. 
c 
Fixed values obtained from separate measurements of Cu2+ without ligand. 
 
The tridentate (O−, N1, S) coordination mode of Pro-STSC was confirmed by X-ray 
diffraction structure of [Cu((R)-H2L)Cl]Cl (Figure 1). It should be also noted (based on the 
stability constants) that the species [CuL] is highly stable even at micromolar concentrations, 
and practically does not dissociate at physiological pH. 
 
In the Zn2+ – L-Pro-STSC system analogous complexes with 1:1 metal-to-ligand ratio were 
detected, although, with considerably lower stability compared to copper(II) species. The 
speciation model obtained for the zinc(II) complexes was supported by 1H NMR titrations 
(Figure 8). In the first instance a slow ligand-exchange process was found with respect to the 
NMR time scale as the chemical shifts of the protons of the metal-free and the bound ligand 
can be seen separately. At pH < 4 only the peaks of the metal-free ligand are present. A new 
set of signals can be found additionally with increasing pH, which most probably belongs to 
the minor protonated complex [ZnLH]+. These signals with a slightly shifted position become 
predominant between pH 6.5 and 9 where the species [ZnL] is formed. There was no free 
ligand detected at 1:1 metal-to-ligand ratio at pH > 6.5. Another species, the mixed hydroxido 
[ZnLH−1]
− (=[ZnL(OH)]−) starts to be formed at pH > 8.5, its proton resonances are well-
separated from those of [ZnL] due to relatively slow ligand-exchange equilibrium between 
them (Figure S9). Distribution of the ligand between the bound and unbound fraction at 1:1 
metal-to-ligand ratio was calculated on the basis of the integrated area of the signals of the 
various ligand protons, and the result is in a good agreement with the concentration 
distribution curves calculated with the stability constants (Figure 9). 
 
18 
 
metal-free ligand
[ZnL]
[ZnLH]+
[ZnLH-1]-
 
Figure 8. pH-dependent 1H NMR spectra of the Zn2+ − L-Pro-STSC {cligand = 2.0 × 10
–3 M; 
M : L = 1:1; 30% (w/w) d6-DMSO/H2O}. 
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Figure 9. Concentration distribution curves for the Zn2+ – L-Pro-STSC system (solid lines) 
calculated on the basis of the stability constants together with the molar fraction of the bound 
ligand (●) estimated from the integrated area of the signals of the C14H; C4H; C6H; C7H3, 
C8H2 protons {cligand = 2.0 × 10
–3 M; M : L = 1:1; 30% (w/w) d6-DMSO/H2O}. 
 
Due to the ability of Fe2+ and Fe3+ ions to form octahedral complexes, bis-ligand iron species 
could be detected as well (Table 2). In the protonated iron complexes (O−, N1, S) coordination 
mode is supposed when the non-coordinating hydrazinic N2 atom is protonated, and in the 
[ML2] type species the ligand binds via (O
−, N1, S−) donor set based on the X-ray diffraction 
structures of complexes of analogous TSCs.32–35 Species [ML2H–1] formed at basic pH are 
most probably mixed hydroxido species in which a coordinated donor group is displaced by 
an OH–. UV−vis spectrophotometric titrations of the Fe2+ – L-Pro-STSC system under strictly 
anaerobic conditions show that the formation of the mono-ligand iron(II) species resulted in a 
shoulder between 430 and 480 nm, whereas formation of the green bis-ligand complexes was 
accompanied by the development of a wide absorption band with maximum at ca. 600 nm 
(not shown here). The absorbance values at 520 nm are increased mainly due to the formation 
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of the bis-ligand complexes (Figure 10). These FeII species have intense color, although their 
molar absorptivities are considerably lower compared to those of the (N)-pyridyl TSC 
complexes.23b,23c In the case of the FeIII complexes CT bands are found to be strongly 
overlapped with the ligand bands (Figure S10) and the pH-dependent UV−vis spectra indicate 
the predominant formation of the [Fe(III)L2]
− complex (lmax = 374 nm; e374nm= 18600 
M−1cm−1) between pH 6.8 and 9.8 even in a diluted solution (c = 2×10−5 M), as it is expected 
on the basis of pH-metry (Figure S10). As a consequence of the high stability of the Fe3+ – L-
Pro-STSC complexes, the bis-ligand species is able to preserve its original integrity almost 
completely with dilution up to the micromolar concentration range at physiological pH, while 
the iron(II) complexes with much lower stability can dissociate to the mono-ligand species 
with decreasing analytical concentrations (Figure 11). Comparing the stability of the iron L-
Pro-STSC complexes to that of the (N)-pyridyl TSCs it can be noted that the substitution of 
the pyridyl moiety by the phenolic one results in an increased binding ability for Fe3+ and 
diminished for Fe2+ at pH 7.4, as it was found for the STSC complexes previously.29 
0.0
0.1
0.2
0.3
0.0
0.2
0.4
0.6
0.8
1.0
2 4 6 8 10
A
b
s
o
rb
a
n
c
e
  (5
2
0
 n
m
)
m
o
la
r 
fr
a
c
ti
o
n
pH
Fe2+
[FeLH]+
[FeL]
[FeL2H-1]
3-
[FeL2]
2-
[FeL2H]
-
 
Figure 10. Concentration distribution curves for the Fe2+ – L-Pro-STSC system (solid lines) 
calculated on the basis of the stability constants together with the molar fraction of the 
absorbance values plotted against pH at 520 nm (×){cligand = 2.0 × 10
–4 M; M : L = 1:2; T = 
298 K, I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}. 
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Figure 11. Representative concentration distribution diagram for the Fe2+ (grey lines) and 
Fe3+ (black lines) – L-Pro-STSC bis-ligand complexes at various total concentrations at pH 
7.4 {T = 298 K; M:L = 1:2; I = 0.10 M (KCl) in 30% (w/w) DMSO/H2O}. 
 
As ligand L-Pro-STSC is strongly fluorescent at physiological pH (see above) the effect of 
the metal ion binding on the emission was also investigated. The metal coordination can 
quench the intensity but at different extent depending on metal ions (Figure S11). Fe3+ and 
Cu2+ quench almost completely the emission. The fluorescence is still observed in the 
presence of Zn2+ and Fe2+, and might be satisfactory for monitoring the cellular distribution of 
these complexes by fluorescence microscopy.   
 
Cytotoxicity in Cancer Cell Lines. The capacity of inhibiting cancer cell growth in vitro of 
compounds L-Pro-STSC and D-Pro-STSC and their corresponding copper(II) complexes was 
determined in human CH1 (ovarian carcinoma) and SW480 (colon carcinoma) cells by means 
of the colorimetric MTT assay. IC50 values are displayed in Table 4. Remarkably, 
complexation with copper(II) results in a marked increase of antiproliferative activity in both 
cell lines, with IC50 values being substantially lower than those of the ligand as well as those 
of a simple copper(II) salt (CuCl2), indicating that cytotoxicity of the complexes cannot be 
explained by their potential dissociation products. The ESI mass spectra of [Cu(L-Pro-
STSC)Cl]Cl in minimum essential medium (containing a variety of biological chelating 
ligands, e.g. amino acids) measured over 22 h indicate that the complex is resistant to 
transchelation (Figure S12). The IC50 values of [Cu(L-Pro-STSC)Cl]Cl in CH1 and SW480 
are 4.6 and 5.5 µM, respectively, whereas [Cu(D-Pro-STSC)Cl]Cl shows IC50 values of 14 
and 12 µM, respectively. In contrast, L-Pro-STSC and D-Pro-STSC showed a moderate 
cytotoxic potency with IC50 values of 62 and 75 µM in CH1 cells, respectively. In SW480 
cells no IC50 value could be determined within the chosen range of concentrations up to 100 
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µM. Comparing IC50 values of L-Pro-STSC and D-Pro-STSC with those of their copper(II) 
complexes in CH1 cells, complexation with copper(II) hence results in a 13-fold and 5-fold 
increase in cytotoxicity. In both tested cell lines the ligand as well as the complex with an L-
proline moiety led to slightly improved antiproliferative activity than the compounds with a 
D-proline moiety. Assuming that the presence of the proline moiety results in an interference 
with the cellular amino acid metabolism, this might reflect an influence of stereoselectivity of 
certain components of this metabolism, which normally deals only with the L isomers.  
 
Table 4. Cytotoxicity of L-Pro-STSC and D-Pro-STSC and their copper(II) complexes 
compared to copper(II) chloride in two human cancer cell lines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Final remarks. Stability and stoichiometry of Cu2+, Zn2+, Fe2+ and Fe3+ complexes of L-Pro-
STSC were determined by pH-potentiometry, and the speciation was confirmed. The most 
feasible coordination modes were proposed based on various spectroscopic methods (EPR, 1H 
NMR, CD, UV−vis). Formation of mono-ligand complexes for Cu2+ and Zn2+ was found, 
while Fe2+ and Fe3+ ions form in addition to mono-ligand complexes bis-ligand species. In the 
protonated complexes the tridentate coordination mode via the (O−, N1, S) set with protonated 
non-coordinating hydrazinic N2 atom is the most probable. (O−, N1, S−) coordination mode is 
realized in [ML] and [ML2] complexes, while formation of mixed hydroxido species is found 
at basic pH values. Complexes [Fe(III)L2]
− and [CuL] possess so high stability that their 
dissociation at physiological pH hardly takes place at the micromolar, the biologically more 
 IC50 [µM]
a 
 SW480 CH1 
L-Pro-STSC > 100   62 ± 3 
[Cu(L-Pro-STSC)Cl]Cl 5.5 ± 0.4 4.6 ± 0.6 
D-Pro-STSC > 100   75 ± 8 
[Cu(D-Pro-STSC)Cl]Cl 12 ± 1 14 ± 2 
CuCl2∙2H2O
b                    > 160                     43           3 
a 50% inhibitory concentrations in SW480 and CH1cells 
after exposure for 96 h in the MTT assay. Values are the 
mean ± standard deviation obtained from at least three 
independent experiments. 
b taken from ref. 36. 
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relevant, concentration range. However, the extent of the complex dissociation in the case of 
the lower stability Zn2+ and Fe2+ species is significant. The complexes formed with L-Pro-
STSC exhibit fairly similar behavior compared to STSC, the reference model compound, 
regarding the type, the stability and coordination mode, although, formation of somewhat 
higher stability Fe3+-complexes is found with L-Pro-STSC. The effect of the side chain 
proline moiety is mainly manifested in the increase of the water-solubility of the ligand and 
its metal complexes. 
 
Whereas the thiosemicarbazone-proline conjugates L-Pro-STSC and D-Pro-STSC show only 
a moderate cytotoxic potency in cancer cells, the corresponding copper(II) complexes display 
a tremendously increased potency. L-Pro-STSC as well as its copper(II) complex show 
slightly higher antiproliferative activity than the compounds with a D-Pro moiety. Studies on 
the impact of copper(II) coordination of proline-thiosemicarbazones on the topoisomerase II 
inhibition and the antiproliferative activity in cancer cells expressing different levels of 
topoisomerase II are underway, since the increased potency of copper(II) complexes cannot 
be explained by the difference in lipophilicity alone. 
 
Experimental 
 
Chemicals 
2-Hydroxy-5-methylbenzaldehyde, thiosemicarbazide, triethylamine were purchased from 
Acros Organics, whereas methyl (S)-pyrrolidine-2-carboxylate hydrochloride was from VWR 
and methyl (R)-pyrrolidine-2-carboxylate hydrochloride from Alfa Aesar. 3-(Chloromethyl)-
2-hydroxy-5-methylbenzaldehyde was synthesized according to the slightly modified 
published procedure.30 Prolonged reaction time (2 h) resulted in a 15% increase of the yield.  
CuCl2, ZnCl2 and FeCl3 (puriss, Reanal) were dissolved in known amount of HCl in order to 
get the Cu2+, Zn2+ and Fe3+ stock solutions, respectively. Their concentrations were 
determined by complexometry via the EDTA complexes. The Fe2+ stock solution was 
obtained from fine Fe powder (puriss, Reanal) dissolved in a known amount of HCl solution 
under a purified, strictly oxygen-free argon atmosphere, then filtered, stored and used under 
anaerobic conditions. KSCN (Sigma-Aldrich) solution was used to check the absence of Fe3+ 
traces in the Fe2+ stock solution. The concentration of the Fe2+ solution was determined by 
permanganometric titrations under acidic conditions. Accurate strong acid content of the 
metal stock solutions was determined by pH-potentiometric titrations. 
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Synthesis of ligands 
(S)-1. To a solution of 3-(chloromethyl)-2-hydroxy-5-methylbenzaldehyde (1.34 g, 7.25 
mmol) in THF (50 mL) was added under stirring a solution of methyl (S)-pyrrolidine-2-
carboxylate hydrochloride (1.49 g, 9.00 mmol) in CH2Cl2 (50 mL). Afterwards, triethylamine 
(2.52 mL, 18.00 mmol) in THF (25 mL) was added and stirring continued at room 
temperature overnight. Next day, the reaction mixture was diluted with THF (300 mL) and 
the precipitate of triethylammonium chloride was filtered off. The solution was freed from 
solvent under reduced pressure and the residue was purified by column chromatography by 
using as eluent ethyl acetate/hexane 3:7. The product was dried in vacuo. Yield: 1.02 g, 51%. 
Anal. Calcd for C15H19O4N (Mr 277.32 g/mol) (%): C, 64.97; H, 6.91; N, 5.05. Found: C, 
64.85; H, 6.67; N, 4.98. 1H NMR (DMSO-d6, δ) 10.29 (s, 1H, HC=O), 7.38 (s, 1H, Ar), 7.26 
(s, 1H, Ar), 4.08 (d, 1H, J = 13.98 Hz, CH2), 3.68 (s, 3H, -OCH3), 3.6 (d, 1H, J = 13.98 Hz, 
CH2), 3.48–3.43 (m, 1H, Pro), 2.92–2.86 (m, 1H, Pro), 2.42–2.36 (m, 1H, Pro), 2.24 (s, 3H, 
CH3) 2.22–2.16 (m, 1H, Pro), 1.91–1.70 (m, 3H, Pro).
 13C{1H} NMR (DMSO-d6, δ): 191.49; 
174.45; 158.86; 136.73; 128.17; 127.65; 125.50; 122.40; 65.03; 55.27; 53.02; 52.41; 29.52; 
23.57; 20.32. ESI-MS in MeOH (negative): m/z 276 [M−H]–. 
 
(R)-1. To a solution of 3-(chloromethyl)-2-hydroxy-5-methylbenzaldehyde (1.95 g, 10.6 
mmol) in THF (50 mL) was added under stirring a solution of methyl (R)-pyrrolidine-2-
carboxylate hydrochloride (2.51 g, 15.1 mmol) in CH2Cl2 (50 mL). Afterwards, triethylamine 
(4.5 mL, 30.0 mmol) in THF (14 mL) was added and stirring continued at room temperature 
overnight. Next day, the reaction mixture was diluted with THF (300 mL) and the precipitate 
of triethylammonium chloride was filtered off. The solution was freed from solvent and the 
residue was purified by column chromatography by using as eluent ethyl acetate/hexane 3:7. 
The product was dried in vacuo. Yield: 1.14 g, 39%. Anal. Calcd for C15H19NO4 (Mr 277.32 
g/mol) (%): C, 64.97; H, 6.91; N, 5.05. Found: C, 64.85; H, 6.67; N, 4.98. 1H NMR (DMSO-
d6, δ): 10.29 (s, 1H, HC=O), 7.38 (s, 1H, Ar), 7.26 (s, 1H, Ar), 4.08 (d, 1H, J = 13.90 Hz, 
CH2), 3.68 (s, 3H, -OCH3), 3.60 (d, 1H, J = 13.90 Hz, CH2), 3.48–3.43 (m, 1H, Pro), 2.92–
2.86 (m, 1H, Pro), 2.42–2.36 (m, 1H, Pro), 2.24 (s, 3H, CH3) 2.22–2.16 (m, 1H, Pro), 1.91–
1.70 (m, 3H, Pro). 13C{1H} NMR (DMSO-d6, δ): 191.45; 174.43; 158.86; 136.70; 128.15; 
127.61; 125.48; 122.39; 65.01; 55.28; 53.00; 52.39; 29.51; 23.56; 20.30. ESI-MS in MeOH 
(negative): m/z 276 [M−H]–. ESI-MS in MeOH (positive): m/z 278 [M+H]+. 
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2-Hydroxy-3-methyl-(S)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde thiosemicar-
bazone (L-Pro-STSC). To a warm solution of the (S)-1 (1.14 g, 4.10 mmol) in ethanol (30 
mL) was added a solution of thiosemicarbazide (0.46 g, 5.00 mmol) in hot water (30 mL). 
The reaction mixture was heated at 70−75°C with continuous stirring for 75 h. After cooling 
to room temperature chloroform (100 mL) was added. The aqueous phase was separated and 
allowed to stand at 5 °C overnight. The white precipitate was filtered off, washed with water, 
ethanol, chloroform and dried in vacuo. Yield: 0.56 g, 41%. Anal. Calcd for 
C15H20N4O3S∙1.5H2O (Mr 363.4 g/mol) (%): C, 49.57; H, 6.38; N, 15.42; S, 8.82. Found: C, 
49.62; H, 6.37; N, 15.51; S, 9.07. 1H NMR (DMSO-d6, δ): 11.41 (s, 1H, N
2H); 8.39 (s, 1H, 
HC14=N2); 8.11 (s, 1H, N3H2); 7.91 (s, 1H, N
3H2); 7.75 (s, 1H, C
4H); 6.95 (s, 1H, C6H); 4.14 
(d, 1H (J = 13.52 Hz), C8H); 3.49 (d, 1H (J = 13.52 Hz), C8H); 3.39–3.37 (m, 1H, C9H); 
2.93–2.84 (m, 1H, C12H); 2.45–2.36 (m, 1H, C12H); 2.27–2.23 (m, 1H, C10H); 2.21 (s, 3H, 
C7H3); 1.91–1.78 (m, 2H, C
10H, C11H); 1.77–1.66 (m, 1H, C11H). 13C{1H} NMR (DMSO-d6, 
δ): 178.11; 174.94; 154.60; 139.61; 131.83; 127.79; 126.11; 123.46; 120.61; 65.59; 56.39; 
53.04; 29.46; 23.46; 20.5. ESI-MS in MeOH (positive): m/z 359 [H2L+Na]
+; 337 [H2L+H]
+. 
 
2-Hydroxy-3-methyl-(R)-pyrrolidine-2-carboxylate-5-methylbenzaldehyde thiosemicar-
bazone (D-Pro-STSC). To a warm solution of (R)-1 (2.05 g; 7.40 mmol) in ethanol (30 mL) 
was added a solution of thiosemicarbazide (0.78 g, 8.50 mmol) in hot water (30 mL). The 
reaction mixture was heated at 70−75°C with continuous stirring for 12 h. After cooling to 
room temperature chloroform (100 mL) was added. The aqueous phase was separated and 
allowed to stand at 5 °C overnight. The white precipitate was filtered off, washed with water, 
ethanol, chloroform and dried in vacuo. Yield: 0.45 g, 18%. Anal. Calcd for 
C15H20N4O3S∙H2O (Mr 354.43 g/mol) (%): C, 50.83; H, 6.26; N, 15.81; S, 9.05. Found: C, 
51.05; H, 6.21; N, 15.84; S, 9.20. 1H NMR (DMSO-d6, δ): 11.41 (s, 1H, NH); 8.39 (s, 1H, 
HC=N); 8.11 (s, 1H, NH2); 7.91 (s, 1H, NH2); 7.75 (s, 1H, Ar); 6.95 (s, 1H, Ar); 4.14 (d, 1H 
(J = 13.52 Hz), CH2); 3.50 (d, 1H (J = 13.52 Hz), CH2); 3.39–3.37 (m, 1H, Pro, overlapped 
water peak); 2.93–2.84 (m, 1H, Pro); 2.45–2.36 (m, 1H, Pro); 2.27–2.23 (m, 4H, Pro, CH3); 
1.91–1.78 (m, 2H, Pro); 1.77–1.66 (m, 1H, Pro). 13C{1H} NMR (DMSO-d6, δ): 178.12; 
174.92; 154.60; 139.63; 131.84; 127.8; 126.14; 123.44; 120.61; 65.59; 56.37; 53.04; 29.46; 
23.45; 20.5. ESI-MS in MeOH (positive): m/z 359 [H2L+Na]
+; 337 [H2L+H]
+. 
 
Synthesis of copper(II) complexes  
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[Cu(S-H2L)Cl]Cl. To a solution of L-Pro-STSC (0.04 g, 0.12 mmol) in methanol (50 mL) 
was added a solution of CuCl2∙2H2O (0.04 g, 0.26 mmol) in methanol (3 mL) and the reaction 
mixture was refluxed for 1 h. After cooling to room temperature the solution was evaporated 
under reduced pressure to about 5 mL. The green crystalline product was obtained by slow 
vapor diffusion of diethylether into the concentrated methanolic solution. The product was 
washed with diethylether/methanol 5:1 (5 mL) and dried in vacuo overnight. Yield: 0.03 g; 
55.4%. Anal. Calcd for CuC15H20N4O3SCl2∙0.4CH3OH (Mr 483.68 g/mol) (%): C, 38.24; H, 
4.5; N, 11.58; S, 6.63. Found: C, 38.05; H, 4.45; N, 11.23; S, 6.48. ESI-MS in MeOH 
(positive): m/z 398 [CuII(HL)]+. ESI-MS in MeOH (negative): m/z 396 [CuII(L−H)]−; m/z 432 
[CuII(L)Cl]−. 
 
[Cu(R-H2L)Cl]Cl. To a solution of D-Pro-STSC (0.04 g, 0.12 mmol) in methanol (50 mL) 
was added a solution of CuCl2∙2H2O (0.04 g, 0.26 mmol) in methanol (3 mL) and the reaction 
mixture was refluxed for 1 h. After cooling to room temperature the solution was evaporated 
under reduced pressure to about 5 mL. The green crystalline product was obtained by slow 
vapor diffusion of diethylether into the concentrated methanolic solution. The product was 
washed with diethylether/methanol 5:1 (5 mL) and dried in vacuo overnight. Yield: 0.05 g, 
83.9%. Anal. Calcd for CuC15H20N4O3SCl2∙0.3CH3OH (Mr 480.47 g/mol) (%): C, 38.25; H, 
4.45; N, 11.66; S, 6.67. Found: C, 37.95; H, 4.35; N, 11.28; S, 6.58. ESI-MS in MeOH 
(positive): m/z 398 [CuII(HL)]+. ESI-MS in MeOH (negative): m/z 396 [CuII(L−H)]−; m/z 432 
[CuII(L)Cl]−. 
 
pH-potentiometric measurements. The purity and aqueous phase stability of the ligand L-
Pro-STSC was verified and the exact concentrations of the stock solutions prepared were 
determined by the Gran method.37 
 
The pH-metric measurements for determination of the protonation constants of the ligand and 
the overall stability constants of the metal complexes were carried out at 25.0 ± 0.1 oC in 
DMSO/water 30:70 (w/w) as solvent and at an ionic strength of 0.10 M (KCl, Sigma-Aldrich) 
in order to keep the activity coefficients constant. (In previous studies on STSC and (N)-
pyridyl TSCs 30% (w/w) DMSO/H2O solvent mixture was used.
23b,23c,29 In order to obtain 
comparable data the same conditions were applied, although the presence of only 20% (w/w) 
DMSO is found to be sufficient for dissolution of L-Pro-STSC at the concentration levels 
necessary for pH-potentiometric titrations, i.e. ≥1−2 mM.) The titrations were performed with 
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carbonate-free KOH solution of known concentration (0.10 M). Both the base and the HCl 
were Sigma-Aldrich products and their concentrations were determined by pH-potentiometric 
titrations. An Orion 710A pH-meter equipped with a Metrohm combined electrode (type 
6.0234.100) and a Metrohm 665 Dosimat burette were used for the pH-metric measurements. 
The electrode system was calibrated to the pH = log[H+] scale in the DMSO/water solvent 
mixture by means of blank titrations (strong acid vs strong base; HCl vs KOH), similarly to 
the method suggested by Irving et al.38 in pure aqueous solutions. The average water 
ionization constant, pKw, is 14.52 ± 0.05 with DMSO/water 30:70 (w/w) as solvent at 25 
oC, 
which corresponds well to the literature data.23b,23c,39 The reproducibility of the titration points 
included in the calculations was within 0.005 pH. The pH-metric titrations were performed in 
the pH range 2.0 – 12.5. The initial volume of the samples was 10.0 mL. The ligand 
concentration was in the range 2−3 × 10–3 M and metal ion-to-ligand ratios of 1:1 – 1:4 were 
used. The accepted fitting of the titration curves was always less than 0.01 mL. Samples were 
deoxygenated by bubbling purified argon through them for ca. 10 min prior to the 
measurements. In the case of Fe2+ samples, argon overpressure was used when Fe2+ was 
added to the samples in tightly closed vessels, which were prior completely deoxygenated by 
bubbling a stream of purified argon through them for ca. 20 min. Argon was also passed over 
the solutions during the titrations. 
 
The protonation constants of the ligands were determined with the computer program 
SUPERQUAD.40 PSEQUAD41 was utilized to establish the stoichiometry of the complexes 
and to calculate the stability constants (log MpLqHr ) from the literature data for Fe
III 
hydroxido complexes.42  MpLqHr  is defined for the general equilibrium pM + qL + rH 
MpLqHr as (MpLqHr) = [MpLqHr]/[M]
p[L]q[H]r where M denotes the metal ion and L the 
completely deprotonated ligand (see SI for details). The calculations were always made from 
the experimental titration data measured in the absence of any precipitate in solution. 
 
UV–vis spectrophotometric, spectrofluorimetric, CD and 1H NMR measurements. A 
Hewlett Packard 8452A diode array spectrophotometer was used to record the UV–vis 
spectra in the interval 260 – 820 nm. The path length was 1 cm. Protonation and stability 
constants and the individual spectra of the species were calculated by the computer program 
PSEQUAD.41 The spectrophotometric titrations were performed on samples of the L-Pro-
STSC alone or with Cu2+, Fe3+ or Fe2+ ions; the concentration of the ligand was 4 × 10–5 M 
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(for the ligand and Fe3+ containing samples), 2 × 10–4 M (for Fe2+ containing samples) or 2 × 
10–3 M (for Cu2+ containing samples) and the metal-to-ligand ratios were 0:1, 1:1 and 1:2 
over the pH range between 2 and 12 at an ionic strength of 0.10 M (KCl) in 30% (w/w) 
DMSO/H2O at 25.0 ± 0.1 
oC. For Fe2+ samples, spectra were recorded under strictly 
anaerobic conditions. Measurements for Fe3+ − L-Pro-STSC system at metal-to-ligand ratio 
1:1 were also carried out by preparing individual samples in which the 0.1 M KCl was 
partially or completely replaced by HCl and pH values, varying in the range ca. 1.0 – 1.8, 
were calculated from the HCl content. For the calculation of the stability constants of the 
protonated mono-ligand Fe3+ – L-Pro-STSC complex mainly CT bands (which are strongly 
overlapped with the ligand bands) were used (l = 300 − 470 nm).  
 
The pH-dependent fluorescence measurements were carried out on a Hitachi-4500 
spectrofluorimeter with the excitation at 393 nm. The emission spectra were recorded using 5 
nm/5 nm slit widths in 1 cm quartz cell in the pH range between 2 and 12 in 30% (w/w) 
DMSO/H2O at 25.0 ± 0.1 
oC. Samples contained 5 × 10–6 M L-Pro-STSC ligand alone or with 
5 × 10–6 M Cu2+ or Zn2+ ions or 2.5 × 10–6 M Fe2+ at 0.1 M (KCl) ionic strength. Three-
dimensional spectra were recorded at 230 – 500 nm excitations and at 240 – 600 nm emission 
wavelengths for the 5 × 10–6 M ligand containing samples at pH 5.1; 7.6 and 10.0 using 2.5 
nm/2.5 nm slit widths. 
 
1H NMR studies were carried out on a Bruker Ultrashield 500 Plus instrument. L-Pro-STSC 
was dissolved in a 30% (w/w) d6-DMSO/H2O mixture in a concentration of 2 × 10
–3 M and 
the Zn2+-to-ligand ratios were 0:1 and 1:1. The direct pH-meter readings were corrected 
according to method of Irving et al.38 
 
CD spectra were recorded on a Jasco J-815 spectrometer in an optical cell of 1.0 cm path 
length. The analytical concentration of D or L-Pro-STSC ligands or the Cu2+-D or L-Pro-
STSC complexes was 6.5 × 10−5 M at pH 7.4 in pure aqueous solution and spectra were 
recorded in the wavelength interval from 215 to 500 nm. 2.0 × 10−3 M ligand concentration 
was used for the Cu2+ − L-Pro-STSC system at 1:1 metal-to-ligand ratio in a 30% (w/w) 
DMSO/H2O mixture and pH was varied between 2 and 12 and spectra were analyzed in the 
range of 460 − 700 nm. CD data are given as the differences in molar absorptivities between 
left and right circularly polarized light, based on the concentration of the ligand (Δε = ΔA / l/ 
cligand or complex). 
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Determination of the distribution coefficient (D). D values of L- and D-Pro-STSC and their 
copper(II) complexes were determined by the traditional shake flask method in n-
octanol/buffered aqueous solution at pH 7.4 (4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, HEPES) at 25.0±0.2 oC as described previously.29 Two parallel experiments were 
performed for each sample. The ligands were dissolved at 4 × 10–5 M and the complexes in 
6.4 × 10–5 M in the n-octanol pre-saturated aqueous solution of the buffer (0.01 M) at constant 
ionic strength (0.10 M KCl). The aqueous solutions and n-octanol with 1:1 phase ratio were 
gently mixed with 360° vertical rotation for 3 h to avoid the emulsion formation, and the 
mixtures were centrifuged at 5000 rpm for 3 min by a temperature controlled centrifuge 
(Sanyo) at 25 oC. After separation UV–vis spectra of the ligands or complexes in the aqueous 
phase were compared to those of the original aqueous solutions and D7.4 value was calculated 
as the mean of (Absorbance (original solution) / Absorbance (aqueous phase after separation) 
– 1) obtained at the region of lmax ± 10 nm values. 
 
EPR measurements and deconvolution of the spectra. All CW-EPR spectra were recorded 
with a BRUKER EleXsys E500 spectrometer (microwave frequency 9.81 GHz, microwave 
power 10 mW, modulation amplitude 5 G, modulation frequency 100 kHz). During titration, 
the isotropic EPR spectra were recorded at room temperature in a circulating system. Eleven 
and ten EPR spectra were recorded for samples with 1:1 and 1:2 Cu2+-to-ligand ratios, 
respectively at 2.0 × 10−3 M L-Pro-STSC concentration between pH 2.4 − 12 in 30% (w/w) 
DMSO/H2O at I = 0.10 M (KCl). KOH solution was added to the stock solution to change the 
pH which was measured with a Radiometer PHM240 pH/ion Meter equipped with a Metrohm 
6.0234.100 glass electrode. A Heidolph Pumpdrive 5101 peristaltic pump was used to 
circulate the solution from the titration pot through a capillary tube into the cavity of the 
instrument. The titrations were carried out under argon atmosphere. At various pH values, 
samples of 0.10 mL were taken, and frozen in liquid nitrogen, and the CW-EPR spectra were 
recorded under the same instrumental conditions as the room-temperature spectra described 
above.  
 
The series of room-temperature CW-EPR spectra were simulated simultaneously by the „two-
dimensional” method using the 2D_EPR program.43 Each component curve was described by 
the isotropic EPR parameters go, Ao
Cu copper hyperfine and Ao
N
 nitrogen hyperfine couplings, 
and the relaxation parameters , ,  which define the line widths in the equation 
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MI=+MI+MI
2, where MI denotes the magnetic quantum number of copper nucleus. The 
concentrations of the complexes were varied by fitting their formation constants 
  MpLqHr) defined by the general equilibrium found in the pH-potentiometric studies 
section.   
 
For each spectrum, the noise-corrected regression parameter (Rj for the j
th spectrum) is 
derived from the average square deviation (SQD) between the experimental and the 
calculated intensities. For the series of spectra, the fit is characterized by the overall 
regression coefficient R, calculated from the overall average SQD. The details of the 
statistical analysis were published previously.44 
 
The anisotropic spectra were analyzed individually with the EPR program,44 which gives the 
anisotropic EPR parameters (gx, gy, gz, Ax
Cu, Ay
Cu, Az
Cu, Ax
N, Ay
N, Az
N, and the orientation 
dependent line width parameters). Since a natural CuCl2 was used for the measurements, the 
spectra were calculated as the sum of the spectra of 63Cu and 65Cu weighted by their natural 
abundances. The quality of fit was characterized by the noise-corrected regression parameter 
Rj as above. The copper and nitrogen coupling constants and the relaxation parameters were 
obtained in field units (Gauss = 10−4 T). 
 
Crystallographic Structure Determination. X-ray diffraction measurement was performed 
on a Bruker X8 APEXII CCD diffractometer. A single crystal of [Cu(R-H2L)Cl]Cl was 
positioned at 40 mm from the detector, and 1138 frames were measured, each for 60 s over 1° 
scan width. The data was processed using SAINT software.45 Crystal data, data collection 
parameters, and structure refinement details are given in Table 5. The structure was solved by 
direct methods and refined by full-matrix least-squares techniques. Non-H atoms were refined 
with anisotropic displacement parameters. H atoms were inserted in calculated positions and 
refined with a riding model. The five-membered proline ring in both crystallographically 
independent complex cations (A and B) of [Cu(R-H2L)Cl]Cl was found to be disordered over 
two positions with s.o.f. 0.50:0.50. In addition, one oxygen atom of the −COOH group in 
complex cation B is also disordered over two positions, each with 50% occupancy. The 
disorder was resolved with restraints on displacement parameters and on bond distances using 
DELU and SADI instructions of SHELX-97, respectively. The following software programs 
and computer were used: structure solution, SHELXS-97; refinement, SHELXL-97;46 
molecular diagrams, ORTEP-3;47 computer, Intel CoreDuo.  
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Table 5. Crystal data and details of data collection for [Cu(R-H2L)Cl]Cl. 
Compound [Cu(R-H2L)Cl]Cl 
Empirical formula  C15H20Cl2CuN4O3S 
Fw 470.85 
Space group P21 
a [Å] 7.3130(3) 
b [Å] 21.8734(8) 
c [Å] 11.7535(5) 
 [°] 99.423(2) 
V [Å3] 1854.72(13)  
Z 4 
l [Å] 0.71073 
calcd [g cm
-3] 1.686 
Crystal size [mm3] 0.16  0.05  0.03 
T [K] 120(2) 
 [mm-1] 1.602 
R1
[a] 0.0356 
wR2
[b] 0.0795 
GOF[c] 1.014 
a R1 = ||Fo|  |Fc||/|Fo|. 
b wR2 = {[w(Fo
2  Fc
2)2]/[w(Fo
2)2]}1/2. c GOF = {[w(Fo
2  
Fc
2)2]/(n  p)}1/2, where n is the number of reflections and p is the total number of parameters 
refined.  
 
Cell lines and Culture Conditions. Human CH1 (ovarian carcinoma) and SW480 (colon 
carcinoma) cells were kindly provided by Lloyd R. Kelland (CRC Centre for Cancer 
Therapeutics, Institute of Cancer Research, Sutton, UK) and Brigitte Marian (Institute of 
Cancer Research, Department of Medicine I, Medical University of Vienna, Austria), 
respectively. Cells were grown in 75 cm² culture flasks (CytoOne/Starlabs, Germany) as 
adherent monolayer cultures in Minimal Essential Medium (MEM) supplemented with 10% 
heat-inactivated fetal bovine serum, 1 mM sodium pyruvate, 4 mM L-glutamine and 1% non-
essential amino acids (from 100 ready-to-use stock) (all purchased from Sigma-Aldrich, 
Vienna, Austria). Cultures were maintained at 37 °C in a humidified atmosphere containing 
5% CO2. 
 
Cytotoxicity Tests in Cancer Cell Lines. Antiproliferative effects were determined by 
means of a colorimetric microculture assay (MTT assay, MTT = 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide). Cells were harvested from culture flasks by 
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trypsinization and seeded in 100 µL aliquots into 96-well microculture plates 
(CytoOne/Starlabs, Germany) in densities of 2 × 103 cells/well (SW480) and 1 × 103 
cells/well (CH1), in order to ensure exponential growth of untreated controls throughout the 
experiment. After a 24 h pre-incubation, dilutions of the test compounds in 100 µL/well 
complete culture medium were added. Because of low aqueous solubility, the test compounds 
were dissolved in DMSO first and then serially diluted in complete culture medium such that 
the effective DMSO content did not exceed 0.5%. After exposure for 96 h, all media were 
replaced by 100 µL/well RPMI 1640 medium (supplemented with 10% heat-inactivated fetal 
bovine serum and 2 mM L-glutamine) plus 20 µL/well MTT solution in phosphate-buffered 
saline (5 mg/ml). After incubation for 4 h, the medium/MTT mixtures were removed, and the 
formazan crystals formed by viable cells were dissolved in 150 µL DMSO per well. Optical 
densities at 550 nm were measured with a microplate reader (Biotek ELx808), using a 
reference wavelength of 690 nm to correct for unspecific absorption. The quantity of vital 
cells was expressed in terms of T/C values by comparison to untreated control microcultures, 
and 50% inhibitory concentrations (IC50) were calculated from concentration-effect curves by 
interpolation. Evaluation is based on means from at least three independent experiments, each 
comprising three microcultures per concentration level. 
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Synopsis 
 
 
The copper(II) complexes [Cu(L-Pro-STSC)Cl]Cl and [Cu(L-Pro-STSC)Cl]Cl are 13 and 5 
times more potent antiproliferative agents in CH1 cells than the free thiosemicarbazone-
proline conjugates L-Pro-STSC and D-Pro-STSC based on comparison of IC50 values. The 
difference in cytotoxicity in SW480 cells is even higher.  
 
 
 
 
